Wikidata entity: Q422618
C₃₇H₄₈N₆O₅S₂ (P274)
Quantities
| P4250 | defined daily dose | 1.2 |
| P2067 | mass | 720.313 |
| P3780 | active ingredient in | ... | Q29006228 (Norvir) | Norvir |
| P3780 | active ingredient in | ... | Q110442458 (nirmatrelvir/ritonavir) | nirmatrelvir/ritonavir |
| P233 | canonical SMILES | String | CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O | ??? |
| P972 | catalog | ... | Q90481889 (CAS COVID-19 Anti-Viral Candidate Compounds) | CAS COVID-19 Anti-Viral Candidate Compounds |
| P373 | Commons category | String | Ritonavir | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q12199 (AIDS) | AIDS |
| P2175 | medical condition treated | ... | Q154869 (hepatitis C) | hepatitis C |
| P2175 | medical condition treated | ... | Q18556697 (HIV infection) | HIV infection |
| P129 | physically interacts with | ... | Q424440 (cytochrome P450 family 3 subfamily A member 4) | cytochrome P450 family 3 subfamily A member 4 |
| P129 | physically interacts with | ... | Q21117300 (cytochrome P450 family 3 subfamily A member 5) | cytochrome P450 family 3 subfamily A member 5 |
| P3489 | pregnancy category | ... | Q3679234 (Australian pregnancy category B3) | Australian pregnancy category B3 |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P769 | significant drug interaction | ... | Q32089 (sirolimus) | sirolimus |
| P769 | significant drug interaction | ... | Q39111 (nifedipine) | nifedipine |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q282629 (vinblastine) | vinblastine |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q407883 (ketoconazole) | ketoconazole |
| P769 | significant drug interaction | ... | Q419769 (bosentan) | bosentan |
| P769 | significant drug interaction | ... | Q422212 (budesonide) | budesonide |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q415159 (rosuvastatin) | rosuvastatin |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q419186 (ergotamine) | ergotamine |
| P769 | significant drug interaction | ... | Q422252 (dexamethasone) | dexamethasone |
| P769 | significant drug interaction | ... | Q422652 (rifampicin) | rifampicin |
| P769 | significant drug interaction | ... | Q423071 (midazolam) | midazolam |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q410412 (carbamazepin) | carbamazepin |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q1002165 (fluticasone) | fluticasone |
| P769 | significant drug interaction | ... | Q1074056 (triamcinolone) | triamcinolone |
| P769 | significant drug interaction | ... | Q1135705 (rifabutin) | rifabutin |
| P769 | significant drug interaction | ... | Q424972 (prednisone) | prednisone |
| P769 | significant drug interaction | ... | Q670131 (simvastatin) | simvastatin |
| P769 | significant drug interaction | ... | Q3011604 (dabrafenib) | dabrafenib |
| P769 | significant drug interaction | ... | Q3935297 (rifapentine) | rifapentine |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q7131441 (panobinostat) | panobinostat |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425729 (ivabradine) | ivabradine |
| P769 | significant drug interaction | ... | Q668093 (atorvastatin) | atorvastatin |
| P769 | significant drug interaction | ... | Q7157043 (pazopanib) | pazopanib |
| P769 | significant drug interaction | ... | Q11426176 (prednisolone) | prednisolone |
| P769 | significant drug interaction | ... | Q906453 (posaconazole) | posaconazole |
| P769 | significant drug interaction | ... | Q907104 (ranolazine) | ranolazine |
| P769 | significant drug interaction | ... | Q21011224 (eliglustat) | eliglustat |
| P769 | significant drug interaction | ... | Q27126905 (docetaxel trihydrate) | docetaxel trihydrate |
| P769 | significant drug interaction | ... | Q27139135 (dasatinib monohydrate) | dasatinib monohydrate |
| P3364 | stereoisomer of | ... | Q27255584 (thiazol-5-ylmethyl (2S,3R,5R)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate) | thiazol-5-ylmethyl (2S,3R,5R)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate |
| P3364 | stereoisomer of | ... | Q27259889 (thiazol-5-ylmethyl (2S,3S,5R)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate) | thiazol-5-ylmethyl (2S,3S,5R)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate |
| P3364 | stereoisomer of | ... | Q27260296 (ritonavir (3R)-hydroxy epimer) | ritonavir (3R)-hydroxy epimer |
| P279 | subclass of | ... | Q193430 (heterocyclic compound) | heterocyclic compound |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q804539 (bactericide) | bactericide |
| P2868 | subject has role | ... | Q846227 (antiviral drug) | antiviral drug |
| P2868 | subject has role | ... | Q50348938 (xenobiotic-transporting ATPase inhibitor) | xenobiotic-transporting ATPase inhibitor |
| P2868 | subject has role | ... | Q50430512 (cytochrome P-450 CYP3A inhibitors) | cytochrome P-450 CYP3A inhibitors |
| P2868 | subject has role | ... | Q55761529 (protease inhibitor) | protease inhibitor |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | ritonavir | ??? |
Why not click here or view trends?
log id: 2031554